Woman's World on MSN
Blood in your urine? 5 bladder cancer symptoms you should never ignore
Nearly 20,000 women are diagnosed with bladder cancer each year, according to the American Cancer Society, with most being ...
Department of Urology, All India Institute of Medical Sciences (AIIMS) Jammu, has commenced advanced endourological services, ...
Providing surgeons feedback and education on their performance significantly improved the quality of bladder cancer operations, finds a new clinical trial led by researchers at UCL, UCLH and the ...
CAPS Medical has successfully completed its first-in-human clinical study, treating approximately 70 tumors and demonstrating durable complete response rates across short and long term follow up. The ...
What Is Zusduri Used For? Zusduri is used to treat a certain type of recurrent, persistent bladder cancer known as LG-IR-NMIBC. About 75% of people with bladder cancer present with non-muscle invasive ...
News that NFL legend Deion Sanders is recovering after a battle with bladder cancer has sparked an important conversation about a form of cancer that is often under-discussed and underfunded in ...
A trans urethral resection of bladder tumour (TURBT) is usually the first treatment you have for non muscle invasive bladder cancer. The surgeon puts a thin rigid tube called a cystoscope into your ...
The FDA has approved mitomycin intravesical solution (Zusduri, UroGen Pharma) for recurrent low-grade intermediate-risk non-muscle invasive bladder cancer. The intravesical mitomycin formulation is ...
PRINCETON, N.J.--(BUSINESS WIRE)--UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, ...
Background information on Bladder Cancer and NMIBC. ZUSDURI (formerly known as UGN-102) is a localized medication designed for potent tumor ablation delivered by innovative RTGel ® technology.
Neoadjuvant mitomycin C showed a favorable safety profile with mild to moderate side effects, including hematuria, dysuria, and itchy scalp. The trial did not show significant improvement in 12-month ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback